Add one more presentation to the list at the EAS 2016 meeting in Austria on May 30th by Dr. Norman Wong. Looks to be an oral presentation.

YIS03 Young Investigator Session

Clinical Epidemiology and Pharmacology

30-May-2016 17:00 18:30

Abstract:

APABETALONE (RVX-208) DECREASES ATHEROGENIC, THROMBOTIC AND INFLAMMATORY MEDIATORS IN VITRO AND IN PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASE (CVD).

Co-authors

N. Wong 1, E. Kulikowski 1, S. Wasiak 1, D. Gilham 1, C. Calosing 1, T. Laura 1, C. Halliday 1, J. Johansson 2, M. Sweeney 2

1Resverlogix Corporation, Pharmacology, Calgary, Canada

2Resverlogix Corporation, Clinical Development, San Francisco, USA